Medtronic gets FDA approval for diabetes-management system

03/17/2010 | Minneapolis/St. Paul Business Journal

Medtronic said it received FDA approval for its MiniMed Paradigm Real-Time Revel System, which features an insulin pump, diabetes therapy management software and continuous blood-sugar monitoring. The device can give early warning alerts to diabetic patients when their blood-sugar levels are below or above the normal range.

View Full Article in:

Minneapolis/St. Paul Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ